Work

Overall responses and survival in RCC on pegilodecakin with anti-PD-1

Year: 2019

Type: article

Source: European Journal of Cancer

DOI: 10.1016/j.ejca.2019.01.025

Authors: A. Naing, J.R. Infante, D.J. Wong, W.M. Korn, R. Aljumaily, K.P. Papadopoulos, K.A. Autio, S. Pant, T.M. Bauer, A. Drakaki, N.G. Daver, A. Hung, R. Verma, N. Ratti, S. McCauley, P. Van Vlasselaer, M. Tannir, M. Oft

Institutions: Sarah Cannon, University of California, Los Angeles, University of California, San Francisco, University of Oklahoma Health Sciences Center, South Texas Accelerated Research Therapeutics, Memorial Sloan Kettering Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2939668334

FWCI:

Cites:

Cited by:

Related to: 10